Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Occupational Status and Hematological Disease

NCT02057185

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti Genzano di Roma, Italy
  • Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy
  • U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy
View Trial Details
Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions
Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations
  • Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom
  • Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom
View Trial Details
Completed

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

NCT03436862

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • HCA Midwest Kansas City, Missouri, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • St. David's South Austin Medical Center Austin, Texas, United States
View Trial Details
Completed

Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

NCT02181738

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Local Institution - 0030 Los Angeles, California, United States
  • Local Institution - 0009 Los Angeles, California, United States
  • Local Institution - 0001 Atlanta, Georgia, United States
  • Local Institution - 0002 Boston, Massachusetts, United States
View all 38 locations
View Trial Details

Related conditions